Literature DB >> 23796192

Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.

J Chen1, D L Kwong, T Cao, Q Hu, L Zhang, X Ming, J Chen1, L Fu, X Guan.   

Abstract

Esophageal cancer is aggressive and has poor prognosis. Esophageal squamous cell carcinoma (ESCC) is histologically the most prevalent type of esophageal cancer and ranked as the sixth leading cause of cancer death worldwide. In recent years, cancer has been widely regarded as genetic disease, as well as epigenetic abnormalities including DNA methylation, histone deacetylation, chromatin remodeling, gene imprinting and noncoding RNA regulation. In this review, we will provide a general overview of genes, proteins and microRNAs that are involved in the development of ESCC, which aims to enhance our understanding of molecular mechanisms implicated in ESCC development and progression.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  MicroRNA; esophageal cancer; proteomics; transcriptomics

Mesh:

Substances:

Year:  2013        PMID: 23796192     DOI: 10.1111/dote.12088

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  25 in total

Review 1.  Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Authors:  Yasushi Sasaki; Miyuki Tamura; Ryota Koyama; Takafumi Nakagaki; Yasushi Adachi; Takashi Tokino
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

2.  Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.

Authors:  Jilisihan Bulibu; Wei Wang; Yong Tang; Na Li; Keyoumu Saifuding
Journal:  Pathol Oncol Res       Date:  2017-12-21       Impact factor: 3.201

3.  High expression of special AT-rich sequence binding protein-1 predicts esophageal squamous cell carcinoma relapse and poor prognosis.

Authors:  Songhui Zhai; Jianxin Xue; Zheng Wang; Lijuan Hu
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

4.  circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.

Authors:  Shifan Zhou; Zhizhong Guo; Chaofeng Zhou; Yu Zhang; Sai Wang
Journal:  Cancer Cell Int       Date:  2021-05-06       Impact factor: 5.722

5.  Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway.

Authors:  Fang Li; Liyuan Zhang; Wei Li; Jieqiong Deng; Jian Zheng; Mingxing An; Jiachun Lu; Yifeng Zhou
Journal:  Oncotarget       Date:  2015-03-20

6.  Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo.

Authors:  Hui Zhao; Xiaomeng Gu
Journal:  World J Surg Oncol       Date:  2014-11-03       Impact factor: 2.754

7.  Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.

Authors:  Jinrong Zhu; Geyan Wu; Qingyuan Li; Hui Gong; Junwei Song; Lixue Cao; Shu Wu; Libing Song; Lili Jiang
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

8.  Circular RNA 0014715 Facilitates Cell Proliferation and Inhibits Apoptosis in Esophageal Squamous Cell Carcinoma.

Authors:  Hao Zhang; Linling Ju; Peipei Hu; Jun Ye; Canlin Yang; Junxing Huang
Journal:  Cancer Manag Res       Date:  2021-06-15       Impact factor: 3.989

9.  LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.

Authors:  Jindun Pan; Yunhong Zang
Journal:  Dig Dis Sci       Date:  2021-07-27       Impact factor: 3.487

10.  Risk factors for precancerous lesions of esophageal squamous cell carcinoma in high-risk areas of rural China: A population-based screening study.

Authors:  Peipei Lu; Jianhua Gu; Nan Zhang; Yawen Sun; Jialin Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.